RecallRadar

FDA Device recall Z-1751-2020

Synchron Systems Opiate 2000 ng Reagent (OP2 1 x 250)

On 2020-04-29 the FDA classified a Class II recall of Synchron Systems Opiate 2000 ng Reagent (OP2 1 x 250) by Beckman Coulter, citing cross-reactivity testing may not meet the claims indicated in the Opiate 2000 ng (OP2) Instructions For Use. The presence of certain compounds in urine may result in false positiv….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1751-2020
ClassificationClass II
Statusterminated
Initiated2019-09-04
Published2020-04-29
Last updated2026-09-13 11:55 UTC
CompanyBeckman Coulter
DistributionAL, AR, AZ, CA, CO, DE, FL, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MS, NC, NJ, NV, NY, OH, OK, OR, PA, PR, SC, TX, VA, WA, WI, WV

Product

Synchron Systems Opiate 2000 ng Reagent (OP2 1 x 250); catalogue no. 475006 for use in conjunction with UniCel DxC 600/800 System(s) and SYNCHRON Systems Drugs of Abuse Testing (DAT) Urine Calibrators. The assay provides a rapid screening procedure for presence of the analyte in urine.

Reason

Cross-reactivity testing may not meet the claims indicated in the Opiate 2000 ng (OP2) Instructions For Use. The presence of certain compounds in urine may result in false positive or false negative patient test results.

Identifiers

code_info
Catalog Number 475006 ; UDI: 15099590222031; Lot Numbers: M904147 and older including M810039, M901087 and M904147) an…Catalog Number 475006 ; UDI: 15099590222031; Lot Numbers: M904147 and older including M810039, M901087 and M904147) and 4 lots OP2 (M805122, M810039, and M901087. .

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1751-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.